In a recent meeting of the North Carolina Senate Appropriations Human Resources Division, lawmakers discussed Senate Bill 2370, which aims to cap the monthly cost of insulin and diabetic supplies for members of the North Dakota Public Employees Retirement System (NDPERS) at $25. This bill builds on the success of a pilot program established under Senate Bill 2140, which had already demonstrated positive outcomes for participants.

The proposed legislation is designed to ensure that individuals with diabetes can access necessary medications without facing exorbitant costs. During the pilot program, it was reported that participants saved an average of $80 per month due to the cap, which significantly alleviated the financial burden associated with insulin and diabetic supplies. The bill is expected to have a minimal impact on premiums, with estimates suggesting a mere 0.12% increase, translating to about $2.07 per contract per month.

While the bill currently focuses solely on NDPERS members, some legislators expressed a desire to expand the cap to the broader commercial market. However, the bill's supporters emphasized the importance of maintaining the cap for NDPERS members to prevent potential health complications that could arise from individuals rationing their insulin due to cost.

The meeting also highlighted the fiscal implications of the bill, with costs expected to be shared among various state and local entities participating in the NDPERS health plan. The discussion underscored the balance between providing essential health benefits and managing the associated costs within the public sector.

As the legislative session progresses, the fate of Senate Bill 2370 remains uncertain, but its potential to improve access to critical health supplies for North Dakota residents is a key concern for lawmakers. The committee's discussions reflect a broader commitment to addressing healthcare affordability and ensuring that individuals with chronic conditions receive the support they need.